Carbamazepine is an inhibitor of histone deacetylases

This publication has 27 references indexed in Scilit:

• The Activity of Antiepileptic Drugs as Histone Deacetylase Inhibitors
  Epilepsia, 2004
• Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824
  Cancer Research, 2004
• Update on new developments in the study of human teratogens
  Teratology, 2002
• Transcriptional Repression of the Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mediated by CCAAT Displacement Protein/cut Homolog, Is Associated with Histone Deacetylation
  Journal of Biological Chemistry, 1999
• Differential Expression of Human Histone Deacetylase mRNAs in Response to Immune Cell Apoptosis Induction by Trichostatin A and Butyrate
  Biochemical and Biophysical Research Communications, 1998
• Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30 +) T-cell lymphoma
  Pathology, 1997
• Segregation of the growth slowing effects of valproic acid from phenytoin and carbamazepine on lymphoid tumor cells
  Life Sciences, 1992
• Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified Cyclodextrins
  Journal of Pharmaceutical Sciences, 1991
• Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy
  New England Journal of Medicine, 1989
• Pseudo-lymphoma associated with carbamazepine
  Clinical and Experimental Dermatology, 1984